Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice
- PMID: 32218
Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice
Abstract
A mixture of antigens was used to detect alterations in immunocompetence. Type III pneumococcal polysaccharide (S3) and tetanus toxoid (TT) stimulate different cellular components, and can therefore be used to assess different compartments of the immune mechanism. Cyclophosphamide (CP), a known immunosuppressant, had a potent effect upon the antibody responses to both S3 and tetanus toxoid. All doses of CP administered within 2 days of priming with S3 resulted in a dose-related immunosuppressive action which persisted even after reinjection of S3. 300 mg/kg of CP given up to 14 days prior to or following primary immunization resulted in a marked suppression of antibodies to S3. Doses of S3 which were partially tolerogenic were made even more so by injections of CP. The effect persisted over a 96 day experimental period. CP also suppressed the formation a memory cells necessary for induction of a secondary-type IgG response to TT. The time of injection for maximum suppression was days 10 to 14 after priming. Therefore, the suppression must involve cellular mechanisms different from those responsible for S3 antibody suppression. In addition, there was a difference in the degree and persistence of the suppressive effect, since the suppressed animals were able to mount an immune response to subsequent injections of TT. Double injections of a high dose (300 mg/kg) of CP 4 weeks after priming completely suppressed the acquired immunity to both S3 and TT. Low and moderate doses of CP appeared to induce a mild augmentation of S3 antibody response when given 4 weeks after priming. However, an immunosuppressive effect occurred if the primed animals were reinjected with S3 or challenged with TT within a period of 2 days prior to or after receiving the CP treatment. Doses of CP, injected prior to challenge and resulting in suppressed tetanus antitoxin production, elevated the titers of specific IgE antibody. This class of antibody is associated with adverse hypersensitivity reactions. These data provided background for the development of models to assess immunocompetence in mice, based on a study of immune profiles following exposure to selected T-dependent and T-independent antigens. Such models may be used to detect potentially hazardous chemicals found in the environment of incorporated into foods, drugs, or cosmetics.
Similar articles
-
Models for assessing the effect of toxicants on immunocompetence in mice. Part I: The effect of diphtheria, pertussis, and tetanus vaccine on antibody response to type III pneumococcal polysaccharide.J Environ Pathol Toxicol. 1978 May-Jun;1(5):689-99. J Environ Pathol Toxicol. 1978. PMID: 31407
-
Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.J Immunol. 1976 Apr;116(4):904-10. J Immunol. 1976. PMID: 3609
-
Secondary IgG responses to type III pneumococcal polysaccharide. I. Kinetics and antigen requirements.J Immunol. 1975 Nov;115(5):1194-8. J Immunol. 1975. PMID: 240888
-
Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).Cancer Res. 1981 Mar;41(3):801-7. Cancer Res. 1981. PMID: 7459867
-
Environment-genetic influences on immunocompetence.J Anim Sci. 1988 Aug;66(8):2091-4. doi: 10.2527/jas1988.6682091x. J Anim Sci. 1988. PMID: 3061994 Review.
Cited by
-
Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.Infect Immun. 1979 Mar;23(3):675-80. doi: 10.1128/iai.23.3.675-680.1979. Infect Immun. 1979. PMID: 37163 Free PMC article.
-
After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments.Clin Exp Immunol. 2003 Jan;131(1):8-16. doi: 10.1046/j.1365-2249.2003.02044.x. Clin Exp Immunol. 2003. PMID: 12519380 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous